This study evaluate the Duodenal Ileal Interposition with Sleeve Gastrectomy for Type 2 Diabetes Mellitus in grade 1 obesity and overweight patients.
A clinical trial, 1-arm treatment (Duodenal Ileal Interposition with Sleeve Gastrectomy for Type 2 Diabetes Mellitus), including 50 research subjects with type 2 diabetes mellitus and obesity class I or overweight. The main objective is to analyse the effect on glycemic control after 2 years of follow-up.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
50
Laparoscopic or open Duodenal Ileal Interposition with Sleeve Gastrectomy
Hospital Federal de Bonsucesso
Rio de Janeiro, Brazil
RECRUITINGRemission of type 2 Diabetes at 24 months
Number of patients with glycated hemoglobin (HbA1c) of 6.0% or less, without use of diabetes medications
Time frame: 2 years
Control of type 2 diabetes
Number of patients with glycated hemoglobin (HbA1c) \< 6.5%, but still in use of oral anti diabetic drugs and/or insulin
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.